Other Species / Isoforms
  Srcasm (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K5-ub
___MAFGksHRDPyA
0 4
Srcasm (human) ___MAFGksHRDPyA K5-ub
Srcasm (mouse) ___MAFGkSHRDPYA K5-ub
Srcasm (rat) ___MAFGKSHRDPYA K5
S6-p
__MAFGksHRDPyAT
0 1
Srcasm (human) __MAFGksHRDPyAT S6-p
Srcasm (mouse) __MAFGkSHRDPYAT S6
Srcasm (rat) __MAFGKSHRDPYAT S6
Y11-p
GksHRDPyATSVGHL
0 7
Srcasm (human) GksHRDPyATSVGHL Y11-p
Srcasm (mouse) GkSHRDPYATSVGHL Y11
Srcasm (rat) GKSHRDPYATSLGHL Y11
K93-ac
SFQSLIVkKEFVkEN
0 1
Srcasm (human) SFQSLIVkKEFVkEN K93-ac
Srcasm (mouse) SFQSLIVKKEFIKDT K93
Srcasm (rat) SFQSLIVKKEFVKDT K93
K98-ub
IVkKEFVkENLVkLL
0 1
Srcasm (human) IVkKEFVkENLVkLL K98-ub
Srcasm (mouse) IVKKEFIKDTLVKLL K98
Srcasm (rat) IVKKEFVKDTLVKLL K98
K103-ub
FVkENLVkLLNPRyN
0 1
Srcasm (human) FVkENLVkLLNPRyN K103-ub
Srcasm (mouse) FIKDTLVKLLNPRYT K103
Srcasm (rat) FVKDTLVKLLNPRYT K103
Y109-p
VkLLNPRyNLPLDIQ
0 4
Srcasm (human) VkLLNPRyNLPLDIQ Y109-p
Srcasm (mouse) VKLLNPRYTLPLETQ Y109
Srcasm (rat) VKLLNPRYTLPLETQ Y109
K148-ub
EVYLDLVkkGVQFPP
0 5
Srcasm (human) EVYLDLVkkGVQFPP K148-ub
Srcasm (mouse) EVYLDLLkKGVQFPP K148-ub
Srcasm (rat) EVYLDLLKKGVQFPP K148
K149-ub
VYLDLVkkGVQFPPS
0 1
Srcasm (human) VYLDLVkkGVQFPPS K149-ub
Srcasm (mouse) VYLDLLkKGVQFPPS K149
Srcasm (rat) VYLDLLKKGVQFPPL K149
S171
RQETAQISSNPPTSV
0 5
Srcasm (human) RQETAQISSNPPTSV S171
Srcasm (mouse) RQEAGQIsPNRPtsV S170-p
Srcasm (rat) KQEAGQIsPSRPTSV S170-p
T176
QISSNPPTSVPTAPA
0 1
Srcasm (human) QISSNPPTSVPTAPA T176
Srcasm (mouse) QIsPNRPtsVPTAPA T175-p
Srcasm (rat) QIsPSRPTSVPTAPA T175
S177
ISSNPPTSVPTAPAL
0 1
Srcasm (human) ISSNPPTSVPTAPAL S177
Srcasm (mouse) IsPNRPtsVPTAPAL S176-p
Srcasm (rat) IsPSRPTSVPTAPAL S176
K191-ub
LSSVIAPkNSTVTLV
0 5
Srcasm (human) LSSVIAPkNSTVTLV K191-ub
Srcasm (mouse) LSSIIAPkNPTISLV K190-ub
Srcasm (rat) LSSIIAPKNPTISLV K190
S207-p
EQIGKLHsELDMVKM
0 1
Srcasm (human) EQIGKLHsELDMVKM S207-p
Srcasm (mouse) EQIGKLHSELDMVKM S206
Srcasm (rat) EQIGKLHSELDMVKM S206
K241-ub
EDIELLQkLYKTGRE
0 1
Srcasm (human) EDIELLQkLYKTGRE K241-ub
Srcasm (mouse) EDIELLRKLYKTGRE K240
Srcasm (rat) EDIELLRKLYKTGRE K240
K298-ub
QRILEQNkNQkEATN
0 4
Srcasm (human) QRILEQNkNQkEATN K298-ub
Srcasm (mouse) QRLLEQKRNRTEATR R297
Srcasm (rat) QRLLEQKRNPTEANQ R297
K298-m2
QRILEQNkNQkEATN
0 1
Srcasm (human) QRILEQNkNQkEATN K298-m2
Srcasm (mouse) QRLLEQKRNRTEATR R297
Srcasm (rat) QRLLEQKRNPTEANQ R297
K301-ub
LEQNkNQkEATNTTS
0 4
Srcasm (human) LEQNkNQkEATNTTS K301-ub
Srcasm (mouse) LEQKRNRTEATRTSS T300
Srcasm (rat) LEQKRNPTEANQTSS T300
S311-p
TNTTSEPsAPsQDLL
0 2
Srcasm (human) TNTTSEPsAPsQDLL S311-p
Srcasm (mouse) TRTSSEPSAPSCDLL S310
Srcasm (rat) NQTSSEPSAPSCDLL S310
S314-p
TSEPsAPsQDLLDLs
0 1
Srcasm (human) TSEPsAPsQDLLDLs S314-p
Srcasm (mouse) SSEPSAPSCDLLDLs S313
Srcasm (rat) SSEPSAPSCDLLNLG S313
S321-p
sQDLLDLsPsPRMPR
Upstream
1 14
Treatment
  • ischemia
Srcasm (human) sQDLLDLsPsPRMPR S321-p
Srcasm (mouse) SCDLLDLsPIVPVPT S320-p
Srcasm (rat) SCDLLNLGPVAPVPV G320
S323-p
DLLDLsPsPRMPRAT
Upstream
0 28
Treatment
  • anti-CD3
  • ischemia
  • nocodazole
Srcasm (human) DLLDLsPsPRMPRAT S323-p
Srcasm (mouse) DLLDLsPIVPVPTPN I322
Srcasm (rat) DLLNLGPVAPVPVSS V322
S342-p
NTMNNQLsGLNFSLP
0 1
Srcasm (human) NTMNNQLsGLNFSLP S342-p
Srcasm (mouse) NSVNAQLSGLSVSSL S341
Srcasm (rat) NSVNAQLSGLNVSSQ S341
Y392-p
NLTSSHAyDNFLEHS
Downstream
3 1
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • endocytosis, altered
Srcasm (human) NLTSSHAyDNFLEHS Y392-p
Srcasm (mouse) NLASSHTyDNFHSNS Y392-p
Srcasm (rat) NLASSHTYDNFPDHS Y392
Y441-p
SDLQPPNyyEVMEFD
2 4
Srcasm (human) SDLQPPNyyEVMEFD Y441-p
Srcasm (mouse) GDLQPPNyyEVMEFD Y440-p
Srcasm (rat) SALQPPSYYEVMEFD Y441
Y442-p
DLQPPNyyEVMEFDP
2 6
Srcasm (human) DLQPPNyyEVMEFDP Y442-p
Srcasm (mouse) DLQPPNyyEVMEFDP Y441-p
Srcasm (rat) ALQPPSYYEVMEFDP Y442
T455-p
DPLAPAVttEAIyEE
0 5
Srcasm (human) DPLAPAVttEAIyEE T455-p
Srcasm (mouse) EFDPLAPTTEAVyEE T452
Srcasm (rat) EFDPLAPTTEAIYEE T453
T456-p
PLAPAVttEAIyEEI
0 2
Srcasm (human) PLAPAVttEAIyEEI T456-p
Srcasm (mouse) FDPLAPTTEAVyEEI T453
Srcasm (rat) FDPLAPTTEAIYEEI T454
Y460-p
AVttEAIyEEIDAHQ
Upstream
Downstream
3 37
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • endocytosis, altered
Treatment
  • EGF
  • FGF2
  • PDGF
Srcasm (human) AVttEAIyEEIDAHQ Y460-p
Srcasm (mouse) APTTEAVyEEIDGYH Y457-p
Srcasm (rat) APTTEAIYEEIDASH Y458